ARTICLE | Company News
Human Genome advances with BLyS
October 30, 2000 8:00 AM UTC
HGSI and Cambridge Antibody Technology (LSE:CAT) extended their 1999 collaboration, as HGSI exercised its option to acquire exclusive global development rights to antibodies generated by CAT against H...